Product Code: ETC4746633 | Publication Date: Nov 2023 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The Angola Influenza Vaccine Market is likely to experience consistent growth rate gains over the period 2025 to 2029. Commencing at 3.05% in 2025, growth builds up to 6.28% by 2029.
Angola's Influenza Vaccine market is anticipated to experience a stable growth rate of 4.97% by 2027, reflecting trends observed in the largest economy Egypt, followed by South Africa, Ethiopia, Algeria and Nigeria.
The influenza vaccine market in Angola is growing as public health initiatives and awareness campaigns emphasize the importance of vaccination. Government efforts to improve healthcare infrastructure and increase vaccine coverage are key drivers. The rising incidence of influenza and the need for preventive healthcare measures are also fueling market growth.
The growth of the Angola influenza vaccine market is driven by increasing awareness about the importance of vaccination and the rising incidence of influenza. Government initiatives to improve immunization coverage and the expansion of healthcare infrastructure also boost market growth. Additionally, advancements in vaccine development technologies and the introduction of new and improved influenza vaccines contribute to market expansion.
The influenza vaccine market in Angola struggles with challenges such as inadequate healthcare infrastructure and limited access to vaccines, especially in rural areas. There is also a significant lack of public awareness about the benefits of vaccination, leading to low uptake rates. Additionally, logistical challenges in vaccine storage and distribution, coupled with periodic shortages, impede the market`s effectiveness.
The government of Angola has established policies to ensure the availability and accessibility of influenza vaccines, including subsidies for vaccine production and distribution, partnerships with international health organizations, and public health campaigns to increase vaccination rates.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Angola Influenza Vaccine Market Overview |
3.1 Angola Country Macro Economic Indicators |
3.2 Angola Influenza Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Angola Influenza Vaccine Market - Industry Life Cycle |
3.4 Angola Influenza Vaccine Market - Porter's Five Forces |
3.5 Angola Influenza Vaccine Market Revenues & Volume Share, By Vaccine type, 2021 & 2031F |
3.6 Angola Influenza Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Angola Influenza Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Angola Influenza Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Angola Influenza Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Angola Influenza Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Angola Influenza Vaccine Market Trends |
6 Angola Influenza Vaccine Market Segmentations |
6.1 Angola Influenza Vaccine Market, By Vaccine type |
6.1.1 Overview and Analysis |
6.1.2 Angola Influenza Vaccine Market Revenues & Volume, By Quadrivalent, 2021-2031F |
6.1.3 Angola Influenza Vaccine Market Revenues & Volume, By Trivalent, 2021-2031F |
6.2 Angola Influenza Vaccine Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Angola Influenza Vaccine Market Revenues & Volume, By Seasonal, 2021-2031F |
6.2.3 Angola Influenza Vaccine Market Revenues & Volume, By Pandemic, 2021-2031F |
6.3 Angola Influenza Vaccine Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Angola Influenza Vaccine Market Revenues & Volume, By Egg-based, 2021-2031F |
6.3.3 Angola Influenza Vaccine Market Revenues & Volume, By Cell-based, 2021-2031F |
6.4 Angola Influenza Vaccine Market, By Age Group |
6.4.1 Overview and Analysis |
6.4.2 Angola Influenza Vaccine Market Revenues & Volume, By Pediatric, 2021-2031F |
6.4.3 Angola Influenza Vaccine Market Revenues & Volume, By Adult, 2021-2031F |
6.5 Angola Influenza Vaccine Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Angola Influenza Vaccine Market Revenues & Volume, By Injection, 2021-2031F |
6.5.3 Angola Influenza Vaccine Market Revenues & Volume, By Nasal Spray, 2021-2031F |
7 Angola Influenza Vaccine Market Import-Export Trade Statistics |
7.1 Angola Influenza Vaccine Market Export to Major Countries |
7.2 Angola Influenza Vaccine Market Imports from Major Countries |
8 Angola Influenza Vaccine Market Key Performance Indicators |
9 Angola Influenza Vaccine Market - Opportunity Assessment |
9.1 Angola Influenza Vaccine Market Opportunity Assessment, By Vaccine type, 2021 & 2031F |
9.2 Angola Influenza Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Angola Influenza Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Angola Influenza Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.5 Angola Influenza Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Angola Influenza Vaccine Market - Competitive Landscape |
10.1 Angola Influenza Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Angola Influenza Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |